Latest Drug Approvals news
FDA Approves New ALS Drug Despite Uncertain Data
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves SPEVIGO for Generalized Pustular Psoriasis Flares
posted September 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Congenital Ichthyosis Linked to Allergic Disorders 
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Oral Engasertib Safe for Hereditary Hemorrhagic Telangiectasia 
Adenotonsillectomy Safe in Children With Down Syndrome, Other Genetic Syndromes Related Articles
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
